Reported about 5 hours ago
Amgen's CEO Robert Bradway announced that the U.S. pharmaceutical company will invest approximately $200 million in a new technology center in Hyderabad, India. The center aims to enhance the use of AI and data science for drug development, with plans for additional investments in the future. Expected to employ around 2,000 people by the end of the year, the center signifies Amgen's commitment to expanding its presence in India, considered the 'pharmacy of the world.'
Source: YAHOO